Quantum Cyber Retains $5M Cash for Manufacturing, Amends Key IP License
QUCY has more than doubled off its 52-week low of $0.3.
Summary
Quantum Cyber N.V. amended its IP license agreement with BP United Inc., retaining a $5 million cash payment for its manufacturing operations and establishing a vesting schedule for consideration shares.
Key Events · Financing and Capital Events · QUCY
-
$5 Million Cash Retained
Quantum Cyber N.V. will retain a $5 million cash payment previously owed to BP United Inc., redirecting these funds towards ramping up its own manufacturing operations for licensed products.
-
IP License Agreement Amended
The Intellectual Property License Agreement with BP United Inc. was amended, shifting from a contemplated Exclusive Supply Agreement to BP United providing manufacturing and consulting services.
-
Consideration Shares Vesting Schedule
The Consideration Shares, which constitute the Upfront Consideration for the IP license, will now vest in four equal quarterly installments on September 30, 2026, March 31, 2027, June 30, 2027, and September 30, 2027.
-
Termination Rights Modified
Quantum Cyber N.V. no longer has the right to terminate the Intellectual Property License Agreement without cause, limiting its flexibility in the partnership.
Analysis · QUCY · Life Sciences
Quantum Cyber N.V. has amended a material intellectual property license agreement, notably retaining a $5 million cash payment that was previously an obligation. For a company with a market capitalization of approximately $55 million and recent disclosures of 'going concern' issues, this $5 million cash retention (nearly 9% of market cap) is a significant positive for its liquidity and ability to fund the ramp-up of its new manufacturing operations. While the amendment also removes Quantum Cyber's right to terminate the agreement without cause, the immediate cash benefit for strategic execution outweighs this limitation.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, QUCY was trading at $2.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $55.8M. The 52-week trading range was $0.30 to $4.93. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.